iRhythm HoldingsIRTC +3.43%75 Days Payable is 8.50 as of Mar. 2026, which is 66% below its 10-year median of 25.14. GuruFocus rates IRTC with a GF Score™ of 75/100 and a GF Value™ of $162.93 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 795 Medical Devices & Instruments companies, iRhythm Holdings ranks worse than 97.48% on this metric.
The historical rank and industry rank for iRhythm Holdings's Days Payable or its related term are showing as below:
IRTC'
s Days Payable Range Over the Past 10 Years
Min: 7.87 Med: 25.14 Max: 36.6
Current: 14
During the past 12 years, iRhythm Holdings's highest Days Payable was 36.60. The lowest was 7.87. And the median was 25.14.
IRTC's Days Payable is ranked worse than 97.48% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs IRTC: 14.00
iRhythm Holdings's Days Payable
declined
from Mar. 2025 (17.68) to Mar. 2026 (8.50).
It may suggest that iRhythm Holdingsaccelerated paying its suppliers.
iRhythm Holdings Days Payable Related Terms
iRhythm Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for iRhythm Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, iRhythm Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where iRhythm Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
iRhythm Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRhythm Holdings (IRTC) has a Days Payable of 8.50 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on iRhythm Holdings and its competitors. This is 66% below median its historical median of 25.14. Over the past decade, iRhythm Holdings' Days Payable has ranged from 7.87 to 36.60. According to the industry distribution chart, iRhythm Holdings ranks #775 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 97.5%.
Is iRhythm Holdings' Days Payable too high?
iRhythm Holdings' current Days Payable of 8.50 is 66% below median its 10-year median of 25.14. Over the past 10 years, this metric has ranged from a low of 7.87 to a high of 36.60. The Medical Devices & Instruments industry median Days Payable is 67.87. iRhythm Holdings' value of 8.50 is 87.5% below this industry median. Based on the distribution chart, iRhythm Holdings ranks #775 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iRhythm Holdings has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRhythm Holdings' Days Payable compare to LIVN and HAE?
According to the Medical Devices & Instruments industry distribution chart, iRhythm Holdings ranks #775 out of 795 companies for Days Payable. This places iRhythm Holdings in the lower half of its industry. The industry median Days Payable is 67.87. iRhythm Holdings' value of 8.50 is 87.5% below this benchmark. Historically, iRhythm Holdings' own Days Payable has ranged from 7.87 to 36.60 over the past decade. While the company's 10-year median is 25.14 vs. the industry median of 67.87, iRhythm Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iRhythm Holdings's current Days Payable of 8.50 is 87.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on iRhythm Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRhythm Holdings's current Days Payable is 8.50, which is 66% below median its own 10-year median of 25.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRhythm Holdings stock overvalued right now?
Based on GuruFocus' analysis, iRhythm Holdings (IRTC) is currently considered Modestly Undervalued. The stock's GF Value™ is $162.93, compared to a current price of $119.95 — trading 26.4% below its estimated fair value. The current Days Payable is 8.50, which is 66% below median its 10-year median of 25.14 and 87.5% below the Medical Devices & Instruments industry median of 67.87. iRhythm Holdings' overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For iRhythm Holdings (IRTC), the current Days Payable is 8.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRhythm Holdings (IRTC) Overvalued in 2026?
Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued.
The current stock price of $119.95 is trading 26.4% below its estimated GF Value™ of $162.93.
GuruFocus considers iRhythm Holdings to be Modestly Undervalued.
Key valuation signals for IRTC:
Days Payable: 8.50 (66% below median its 10-year median of 25.14)
GF Value™: $162.93 vs. price of $119.95 (26.4% below fair value)
Industry Position: 87.5% below the Medical Devices & Instruments median (#775 of 795)
No single metric tells the full story. See the IRTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
75GF Score
Get the complete analysis for IRTC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRTC has been successfully added to your 
